Brian Lenz, Chief Financial Officer at ADMA BIOLOGICS, INC. (ADMA), bought 500 shares at $9.80 ($5K) on 2014-08-13, disclosed to the SEC on 2014-08-15.
Open-market purchase of $5k ADMA by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ADMA | BUY | 2021-10-26 | $30K | — | Filing → |
| ADMA | BUY | 2020-08-12 | $12K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $25K | — | Filing → |